Peritonitis with Atypical Organisms

Similar documents
Standing Orders for the Treatment of Outpatient Peritonitis

Standing Orders for the Treatment of Outpatient Peritonitis

Diagnosis: Presenting signs and Symptoms include:

Randomized Controlled Trial on Adjunctive Lavage for Severe Peritoneal Dialysis- Related Peritonitis

TREATMENT OF PERITONEAL DIALYSIS (PD) RELATED PERITONITIS. General Principles

ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment

The CARI Guidelines Caring for Australians with Renal Impairment. 10. Treatment of peritoneal dialysis associated fungal peritonitis

Protocol for exit-site care and treatment of exit-site infections in peritoneal dialysis CONTROLLED DOCUMENT

2. Peritoneal dialysis-associated peritonitis in children

Treatment of peritonitis in patients receiving peritoneal dialysis Antibiotic Guidelines. Contents

St George/Sutherland Hospitals And Health Services (SGSHHS)

Empiric antimicrobial use in the treatment of dialysis related infections in RIPAS Hospital

General Approach to Infectious Diseases

Duke University Hospital Guideline for Empiric Inpatient Treatment of Cancer- Related Neutropenic Fever in Adult Patients

To guide safe and appropriate selection of antibiotic therapy for Peritoneal Dialysis patients.

The CARI Guidelines Caring for Australians with Renal Impairment. 8. Prophylactic antibiotics for insertion of peritoneal dialysis catheter

Antibiotic stewardship in long term care

Interactive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe

Central Nervous System Infections

Northwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16

Guideline for the diagnosis and treatment of PD peritonitis and exit site infections in adults

Approach to pediatric Antibiotics

PERITONEAL DIALYSIS PERITONITIS - DIAGNOSIS AND TREATMENT

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

Treatment of septic peritonitis

Treatment of peritoneal dialysis associated fungal peritonitis

INFECTIOUS COMPLICATIONS OF PERITONEAL DIALYSIS

Comparison of Gentamicin and Mupirocin in the Prevention of Exit-Site Infection and Peritonitis in Peritoneal Dialysis

The new ISPD peritonitis guideline

Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.

Mycobacterium fortuitum as a cause of peritoneal dialysis-associated peritonitis: case report and review of the literature

Inappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012

Appropriate antimicrobial therapy in HAP: What does this mean?

Intra-Abdominal Infections. Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018

CONFLICT OF INTEREST ANTIMICROBIAL LOCK SOLUTIONS INCREASE BACTEREMIA

ISPD GUIDELINES/RECOMMENDATIONS PERITONEAL DIALYSIS-RELATED INFECTIONS RECOMMENDATIONS: 2005 UPDATE

MICRO-ORGANISMS by COMPANY PROFILE

The Inpatient Management of Febrile Neutropenia

Update in Veterinary Medicine. Dr. Maria M. Crane Zoo Atlanta

Appropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases

Disclosures. Principles of Antimicrobial Therapy. Obtaining an Accurate Diagnosis Obtain specimens PRIOR to initiating antimicrobials

Antibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011

Rational management of community acquired infections

Infectious complications of Peritoneal Dialysis

Preventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal

Infection Comments First Line Agents Penicillin Allergy History of multiresistant. line treatment: persist for >7 days they may be

Infections in Immunocompromised Patients TH 5001: Therapeutics III Fall, 2003 Sara L. Lanfear, Pharm.D., BCPS

Meropenem for all? Midge Asogan ICU Fellow (also ID AT)

Safety of an Out-Patient Intravenous Antibiotics Programme

Management of CRBSI Leilani Paitoonpong MD MSc Chusana Suankratay MD PhD Division of Infectious Diseases Chulalongkorn University

Multi-Drug Resistant Organisms (MDRO)

11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1

* gender factor (male=1, female=0.85)

GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS

Acute Pyelonephritis POAC Guideline

UCSF Medical Center Guidelines for Inpatient Management of Febrile Neutropenia

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

Prophylactic antibiotics for insertion of peritoneal dialysis catheter

microbiology testing services

Dr. Michelle Arnold, DVM DABVP (Food Animal) Ruminant Extension Veterinarian University of Kentucky Veterinary Diagnostic Laboratory

Antibiotic Stewardship Program (ASP) CHRISTUS SETX

9/30/2016. Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS

Objectives. Basic Microbiology. Patient related. Environment related. Organism related 10/12/2017

Zyvox. Zyvox (linezolid) Description

A Randomized, Double-Blinded Study for the Prevention of Exit Site Infections in Pediatric Peritoneal Dialysis Patients

Enterobacteriaceae peritonitis complicating peritoneal dialysis: A review of 210 consecutive cases

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

TITLE: NICU Late-Onset Sepsis Antibiotic Practice Guideline

Role of the nurse in diagnosing infection: The right sample, every time

ORIGINAL ARTICLE. Joanna Kabat Koperska, Edyta Gołembiewska, Kazimierz Ciechanowski

Antibiotic Updates: Part II

LINEE GUIDA: VALORI E LIMITI

13. Treatment of peritoneal dialysis-associated peritonitis in adults

BRUCELLOSIS. Morning report 7/11/05 Andy Bomback

Peritonitis Management in Children on PD

Replaces:04/14/16. Formulated: 1997 SKIN AND SOFT TISSUE INFECTION

Antimicrobial stewardship in managing septic patients

Suitability of Antibiotic Treatment for CAP (CAPTIME) The duration of antibiotic treatment in community acquired pneumonia (CAP)

American Association of Feline Practitioners American Animal Hospital Association

Objectives. Review basic categories of intra-abdominal infection and their respective treatments. Community acquired intra-abdominal infection

Author - Dr. Josie Traub-Dargatz

Other Beta - lactam Antibiotics

Aberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015

Cleaning and Disinfection Protocol Vegetative Bacteria

Antibiotic Stewardship in the Neonatal Intensive Care Unit. Objectives. Background 4/20/2017. Natasha Nakra, MD April 28, 2017

Pharmacology Week 6 ANTIMICROBIAL AGENTS

General Surgery Small Group Activity (Facilitator Notes) Curriculum for Antimicrobial Stewardship

CAVICIDE1. Technical Bulletin

Antibiotic Usage Guidelines in Hospital

In peritoneal dialysis (PD) patients, peritonitis is a serious

Canadian Nosocomial Infection Surveillance Program 2018 SURVEILLANCE FOR HEALTHCARE ACQUIRED CEREBROSPINAL FLUID SHUNT ASSOCIATED INFECTIONS

MICU Antibiotics and Associated Drug Interactions

Int.J.Curr.Microbiol.App.Sci (2017) 6(3):

Drug Class Prior Authorization Criteria Intravenous Antibiotics

Antibiotics in the future tense: The Application of Antibiotic Stewardship in Veterinary Medicine. Mike Apley Kansas State University

CONTAGIOUS COMMENTS Department of Epidemiology

MASTITIS CASE MANAGEMENT

Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems

Transcription:

Peritonitis with Atypical Organisms Gurwant Kaur, MD Assistant Professor of Medicine (Nephrology) Co- director for Medical Students Renal block Penn State College of Medicine Penn State Milton S. Hershey Hospital March 18 th 2019 Conflict Of Interest None 1

Objectives Atypical Mycobacteria Fungal Viral Zoonotic infections PD related infections 1. PD related peritonitis 2. PD catheter related infections: Exit site infection (ESI) Tunnel infection Continuous Ambulatory Peritoneal Dialysis 2

Diagnosis of PD Peritonitis When at least two* of the following are present: Clinical features consistent with peritonitis, i.e., abdominal pain and/or cloudy dialysis effluent Dialysis effluent white cell count above 100/μL or with over 50% of poly leukocyte in the differential count However, among patients with fungal peritonitis, the peritoneal WBC is almost always >200 cells/μl, with a PMN predominance Identification of infective organisms by dialysis effluent gram stain or culture *Cloudy PD effluent Can see through Can't see through Common organisms Gram positive Coagulase negative Staphylococcus (S. epidermidis) Streptococcus spp S. aureus Enterococcus spp Corynebacterium spp. Gram negative Escherichia coli Klebsiella spp Pseudomonas aeruginosa 3

Peritonitis with Atypical Organisms Although uncommon Delay in recognition of PD peritonitis Delay in diagnosis and implementation of appropriate treatment Atypical organisms can lead to poor patient outcomes On Day #3: If clinical improvement narrow down antibiotics (discontinue gram negative coverage) based on local antibiogram If no bacteria identified on PD effluent culture Repeat PD fluid WBC, differential, cultures Duration of the dwell and whether or not peritoneal lavage was performed prior to sample collection If the culture negative peritonitis is not resolving at day# 3 Special culture techniques should be considered for isolation of unusual/atypical organisms M. tuberculosis MAC (avium) Non tuberculosis Mycobacteria (NTM) = Atypical Mycobacterium Mycobacterium tuberculosis Mycobacterium avium complex Mycobacterium abscessus Mycobacterium chelonae Mycobacterium fortuitum Mycobacterium gastri Mycobacterium gordonae Mycobacterium heckeshornense Mycobacterium kansasii Mycobacterium phlei Mycobacterium porcinum Mycobacterium rhodesiae Mycobacterium smegmatis Mycobacterium trivale Mycobacterium xenopi 4

Atypical Mycobacteria PD peritonitis First case: in 1982 > 50 case reports so far (geographical publication bias and variation in accurate diagnosis) Can be misidentified as gram positive diphtheroids In immunosuppressed states: Diabetes, Bone Marrow transplant, HIV and auto immune disease A frequent history of bacterial peritonitis episodes or concomitant bacterial/fungal infections Exit site infection with atypical organism Signs/symptoms: Not much different than other causes of peritonitis Case. 69 Y old female Medical History of HTN, DM, Ischemic heart disease, on APD ~ 40 months Recurrent culture negative exit site infections x 3 months (Rx with topical gentamicin and oral antibiotics) Several tunnel ultrasounds: sub centimeter tunnel abscess Patient preferred to continue PD Subsequent exit site: grew M. abscessus after 12 days Sensitive to only Amikacin and Clarithromycin (No IV access: Amikacin couldn t be given) Rx: Clarithromycin + Ethambutol Ethambutol was stopped due to drug induced psychosis PD fluid cultures remain negative Completed 6 weeks of monotherapy with Clarithromycin Converted back to APD CJ Renaud et al. Nephrology 2010 Asian Pacific Society of Nephrology The Role of Non Tuberculous Mycobacteria in Peritoneal Dialysis Related Infections: A Literature Review. 10 years data, retrospective, observational (Tokyo, Japan)2018 # patients: 44 NTM peritonitis: Catheter removal: in 92.2% Withdrawal of PD: in 91.9%. Overall mortality rate: 12.4% (including unrelated deaths) NTM exit site infections: Developed peritonitis: 33.3% Catheter removal: 50.0%. Patients stopped PD when the catheter was removed without developing peritonitis (37.5%) Patients stopped PD when it was removed after the onset of peritonitis (91.9%) Changing the exit site: in 12.5% Contrib Nephrol. 2018;196:155 161. doi: 10.1159/000485716. Epub 2018 Jul 24. 5

Rx The treatment regimen for non tuberculous mycobacterial peritonitis is not well established and requires individualized protocols based on susceptibility testing Fungal Peritonitis Non candida species Some unusual Fungi i.e. Cryptococcus/Aspergillus Usually delay in diagnosis Red flag: Lymphocytes and/or mononuclear cells in the peritoneal dialysate PD fluid: almost always > 200 cells/microl with PMN cells predominance Rx: Most anti fungal agents should be given systemically 6

Fungal Peritonitis High rates of hospitalization Catheter removal Transfer to hemodialysis Higher morbidity and mortality than bacterial infections Causes of contamination: o Breaks in sterile technique o Infections at the cutaneous site of catheter entry o Intestinal perforation o Peritoneovaginal fistula o Transmigration of fungi across the bowel wall into the peritoneum (avoid constipation) ISPD Unlike bacterial peritonitis, IP anti fungal agent has no preferential role over systemic therapy Suggests the use of echinocandins (e.g. caspofungin) for Aspergillus and non albicans Candida species Second generation azoles (e.g. posaconazole and voriconazole) for filamentous fungi Intravenous voriconazole contains cyclodextrin as solvent, which may accumulate in renal failure patients and cause neurotoxicity 7

Fungal Peritonitis ISPD We recommend immediate catheter removal when fungi are identified in PD effluent (1C). We suggest that treatment with an appropriate anti fungal agent be continued for at least 2 weeks after catheter removal (2C). Case.. 65 year old farmer; presented outpatient with abdominal pain On CAPD ~ 4 years, ESRD from DM Previous PD history: Staph. aureus PD related peritonitis in 1 st year on CAPD 1 PD catheter exit site infection after 2 years on CAPD Pneumonia treated with broad spectrum antibiotics 6 months ago He had PD catheter damaged during catheter care and it was replaced 1 month ago Exam and peripheral blood labs : was unremarkable PD fluid: WBC 431/uL; PD peritonitis was suspected, PD fluid culture were sent 2 gm IP vancomycin was administered with follow up No improvement next day now has fever, so was admitted, BP 110/80 mmhg, Temp. 36 C Subcutaneous tunnel and exit site were unremarkable Peritoneal fluid is now cloudy: WBC 5664/uL RX: IP vancomycin + Ceftazidime only mild clinical improvement Ines Schwetz et al AmJKidneyDis 49:701 704. Case conti.. Day#5: worsened clinical picture, increased abdominal pain, febrile 38.2 C PD fluid WBC of 9742/ ul while on antibiotics Culture obtained on Day #2,5 and 8 were negative Day #14 (while no +ve culture were reported) Clinically deteriorated, T 39.6, HR 120bpm, Blood WBC 14 x 103/uL Day #15: Aspergillus was reported on sample from day #9 (A. oryzar) Day #19 and 20: Same grew from day # 13 (after 6 days) RX: IV Amphotericin B as 1 mg/kg of body weight + Caspofungin (LD 70 mg day 1; MD 50 mg), PD catheter was removed, transitioned to HD 3/week 28 days of Amphotericin + Caspofungin Itraconazole 200mg daily PO x 6 months Discharged on Day# 45 Doing well on HD on 2 years follow up 8

Treatment Goal: Eradication of infection and preservation of peritoneum for future use of dialysis Team approach with Infectious disease specialist Rx: Prolonged course of anti fungal +/ PD catheter removal PD catheter removal Look before removing: is there an alternate access available/or can be created or not) Continuation of PD is possible (Use your best clinical judgment) Antifungal Prophylaxis Routine antifungal prophylaxis is not recommended for all PD patients It can be given in patients receiving prolonged antibiotic therapy Nystatin (400,000 to 500,000 units PO TID) OR Fluconazole (200 mg every other day or 100 mg PO daily) Optimal duration of prophylaxis is unclear Usually administered for duration of antibiotic Extend for additional 3 days in case of Aminoglycosides Extend for additional 7 days in case of vancomycin (as these antibiotics have a prolonged half lives in patients on PD) 9

Viral Peritonitis Fever, malaise (+/ sick contacts with similar features) Negative bacterial and mycobacterial cultures Slight leukopenia PD effluent monocytosis (or absence of polymorphonuclear leukocytes PD effluent (+ Blood/serum): PCR/ antibody titer/ viral cultures ( as appropriate) Enterovirus (Echovirus type II): Antibodies titers Coxsackie virus B1: Antibodies titers HSV type I and II: Intra nuclear viral particles HZV: Antibodies titers CMV: Antibodies titers Case.. 42 year F. ESRD from Diabetes, on CAPD for ~ 1 year Medical History: Failed kidney transplant due to chronic rejection 3 bacterial peritonitis in last year (Stap. Epidermidis, Strep. Mitis and N. Pharyngis) Presented with abdominal pain started after 1 weeks history of her 11 year old son had high fever and headache for few days Cloudy dialysate with WBC 100/uL on day #1, No response with antibiotics; it remained cloudy. Cultures negative for bacteria. Day#3: Dialysate WBC 400/uL and atypical bodies in leucocytes on gram stain Day #10: Enterovirus was isolated from dialysate (Echinovirus type II) Day#13: Fecal cultures +ve as well, Antibodies titers 1:64 Follow up: Day#30 : WBC resolved to 20/uL Dat#41: WBC 0/uL Day #43: Antibodies titers 1:16 Clinical improvement with resolution of culture positivity from dialysate and faeces DG Stujik; Nephron 1986 10

Zoonotic Be aware that PD effluent culture results from zoonotic organisms can take 3 7days Consider a zoonotic cause in culture negative peritonitis Consider mandatory exclusion of pets from room where dialysis takes place Identify mode of transmission Contact with an animal is EVIDENT at time of peritonitis Bite, scratch, or perforation of tubing Lack of hygienic measures before/after exchange Without animal contact Ingestion of contaminated food Skin contamination Bad hand hygiene in general Tube bite by cat B lactam antibiotics+ B lactamase 2 nd generation cephalosporin 2 nd generation Flouroquinolone Pasturella, Capnocytophaga, Neiserria Dog Same as above Capnocytophaga, Pasturella, Listeria, Bordetella SYMPTOMS Diarrhea 2 nd generation Flouroquinolone Salmonella or camylobacter Broughton et al. Seminars in Dialysis 2010 11

Zoonotic Due to vast diversity of infective agents that are potentially transmitted by different animals: it is difficult to make general antibiotic guidelines Catheter removal Refractory peritonitis (failure of the effluent to clear after 5 days (not 96 h as used previously) of appropriate antibiotics (ISPD) Relapsing peritonitis Refractory exit site and tunnel infection Fungal peritonitis Repeat peritonitis, Mycobacterial peritonitis, and peritonitis caused by multiple enteric organisms Catheter Removal and Re Insertion ISPD We recommend that PD catheters be removed for refractory, relapsing, or fungal peritonitis unless there are clinical contraindications (1C). We suggest that it is appropriate to consider return to PD for many patients who have had their catheter removed for refractory, relapsing, or fungal peritonitis (2C). We suggest that if re insertion of a new catheter is attempted after a PD catheter is removed for refractory, relapsing, or fungal peritonitis, it be performed at least 2 weeks after catheter removal and complete resolution of peritoneal symptoms (2D). 12

Refractory PD related peritonitis Antibiotic resistant bacteria Fungal peritonitis Biofilm formation in PD catheters Bacterial translocation from the gastrointestinal tract Encapsulating peritoneal sclerosis Terminology for Peritonitis Important Break in technique No clean space available Physical functional status/ vision/dexterity/ new neurological issues Burden of home dialysis Pets Personal life issues/partner dependence Care taker fatigue Depression Compliance issues Etc.. 13

Thank you Gurwant Kaur, MD Assistant Professor of Medicine (Nephrology) Penn State College of Medicine Penn State Milton S. Hershey Hospital gkaur1@pennstatehealth.psu.edu Thank you & Stay warm 14